Bausch & Lomb Corp revenue by segment BLCO

Annual Quarterly

Bausch & Lomb Corp splits its revenue 2 ways in its filings. By operating segments, the largest line in Q3 of fiscal 2026, the quarter ended Sep 30, 2026 was Vision Care at $774.0 million, 56% of the total. By sales mix, the largest line in Q3 of fiscal 2026, the quarter ended Sep 30, 2026 was Product at $1.4 billion, 100% of the total.

USD in millions. The percent under a figure is the change from the same quarter a year earlier.

Line	TTM Sep 30, 2026	Q3 FY2026 Sep 30, 2026	Q2 FY2026 Jun 30, 2026	Q1 FY2026 Mar 31, 2026	Q4 FY2025 Dec 31, 2025	Q3 FY2025 Sep 30, 2025	Q2 FY2025 Jun 30, 2025	Q1 FY2025 Mar 31, 2025	Q4 FY2024 Dec 31, 2024
Revenue	5,418	1,375	1,394	1,244	1,405	1,281	1,278	1,137	1,280
Operating segments
Vision Care	3,047 +6.2% share 56.2%	774 +5.2% share 56.3%	784 +4.1% share 56.2%	711 +8.4% share 57.2%	778 +7.6% share 55.4%	736 share 57.5%	753 share 58.9%	656 share 57.7%	723 share 56.5%
Pharmaceuticals	1,404 +14.0% share 25.9%	367 +11.2% share 26.7%	354 +14.6% share 25.4%	305 +14.2% share 24.5%	378 +16.0% share 26.9%	330 share 25.8%	309 share 24.2%	267 share 23.5%	326 share 25.5%
Surgical	967 +10.4% share 17.8%	234 +8.8% share 17.0%	256 +18.5% share 18.4%	228 +6.5% share 18.3%	249 +7.8% share 17.7%	215 share 16.8%	216 share 16.9%	214 share 18.8%	231 share 18.0%
Sales mix
Product	5,397 +8.9% share 99.6%	1,371 +7.4% share 99.7%	1,389 +9.2% share 99.6%	1,239 +9.4% share 99.6%	1,398 +9.6% share 99.5%	1,277 share 99.7%	1,272 share 99.5%	1,133 share 99.6%	1,275 share 99.6%
Brandedand Other Generic Products	46 +15.0% share 0.8%	10 +11.1% share 0.7%	13 +30.0% share 0.9%	10 +11.1% share 0.8%	13 +18.2% share 0.9%	9 share 0.7%	10 share 0.8%	9 share 0.8%	11 share 0.9%
Product And Service Other	21 +10.5% share 0.4%	4 +0.0% share 0.3%	5 -16.7% share 0.4%	5 +25.0% share 0.4%	7 +40.0% share 0.5%	4 share 0.3%	6 share 0.5%	4 share 0.4%	5 share 0.4%
Pharmaceutical Products	5 +25.0% share 0.1%	1 +0.0% share 0.1%	1 +0.0% share 0.1%	1 +0.0% share 0.1%	2 +100.0% share 0.1%	1 share 0.1%	1 share 0.1%	1 share 0.1%	1 share 0.1%

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry: Ophthalmic Goods (SIC 3851)
Listed as: BLCO (NYSE)
Fiscal year ends: December 31
Headquarters: Vaughan, Ontario, Canada
SEC filer status: Large accelerated filer
SEC CIK: 1860742

Other Ophthalmic Goods companies

All 8 Ophthalmic Goods companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.